Ken Griffin’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-461,869
| Closed | -$49.3M | – | 14199 |
|
|
2025
Q3 | $49.3M | Sell |
461,869
-934,775
| -67% | -$97.6M | 0.01% | 1387 |
|
|
2025
Q2 | $132M | Buy |
1,396,644
+1,052,924
| +306% | +$78M | 0.02% | 589 |
|
|
2025
Q1 | $21.8M | Sell |
343,720
-1,008,993
| -75% | -$60.4M | ﹤0.01% | 1945 |
|
|
2024
Q4 | $62.8M | Buy |
1,352,713
+174,691
| +15% | +$6.56M | 0.01% | 1082 |
|
|
2024
Q3 | $33.9M | Buy |
1,178,022
+1,075,407
| +1,048% | +$26.5M | 0.01% | 1557 |
|
|
2024
Q2 | $1.48M | Sell |
102,615
-39,597
| -28% | -$578K | ﹤0.01% | 5857 |
|
|
2024
Q1 | $2.29M | Buy |
142,212
+114,022
| +404% | +$1.97M | ﹤0.01% | 5260 |
|
|
2023
Q4 | $560K | Sell |
28,190
-148,293
| -84% | -$2.19M | ﹤0.01% | 7847 |
|
|
2023
Q3 | $2.88M | Sell |
176,483
-109,383
| -38% | -$2.11M | ﹤0.01% | 4554 |
|
|
2023
Q2 | $6.04M | Buy |
285,866
+17,618
| +7% | +$376K | ﹤0.01% | 3350 |
|
|
2023
Q1 | $5.39M | Buy |
+268,248
| New | +$5.79M | ﹤0.01% | 3688 |
|
|
2022
Q4 | – | Sell |
-695,260
| Closed | -$9.26M | – | 15511 |
|
|
2022
Q3 | $7.11M | Buy |
695,260
+684,511
| +6,368% | +$5.77M | ﹤0.01% | 3294 |
|
|
2022
Q2 | $45K | Buy |
+10,749
| New | +$46K | ﹤0.01% | 12005 |
|
|
2022
Q1 | – | Sell |
-11,889
| Closed | -$69.2K | – | 14667 |
|
|
2021
Q4 | $80K | Sell |
11,889
-10,981
| -48% | -$56.1K | ﹤0.01% | 12943 |
|
|
2021
Q3 | $125K | Buy |
+22,870
| New | +$133K | ﹤0.01% | 12596 |
|
|
2019
Q2 | – | Sell |
-10,824
| Closed | -$68K | – | 9921 |
|
|
2019
Q1 | $68K | Buy |
+10,824
| New | +$70.5K | ﹤0.01% | 8707 |
|
Other funds holding VRNA
Ken Griffin's VRNA Position: Q4 2025 in Review
Ken Griffin sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 461,869 shares — an estimated $49.3M sold.
Ken Griffin first reported a position in VRNA in Q1 2019 and held it in 16 quarters. The position peaked at $132M in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.
- Ken Griffin reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
- Ken Griffin sold 461,869 Verona Pharma shares in Q4 2025, an estimated $49.3M.
- Ken Griffin first reported a position in Verona Pharma in Q1 2019 and held it in 16 quarters.
- Ken Griffin's Verona Pharma position peaked at $132M in Q2 2025.
- 1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.